CT
NVO

Clearstead Trust’s Novo Nordisk NVO Stock Holding History

Clearstead Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Sell
6,678
-234
-3% -$10.1K 0.04% 147
2026
Q1 		$254K Sell
6,912
-1,239
-15% -$58.7K 0.04% 159
2025
Q4 		$415K Sell
8,151
-1,120
-12% -$57.3K 0.07% 127
2025
Q3 		$514K Sell
9,271
-1,438
-13% -$84.2K 0.09% 106
2025
Q2 		$739K Buy
10,709
+6,996
+188% +$476K 0.14% 85
2025
Q1 		$258K Buy
3,713
+436
+13% +$36K 0.06% 135
2024
Q4 		$282K Buy
3,277
+2,098
+178% +$227K 0.06% 128
2024
Q3 		$140K Hold
1,179
– – 0.03% 159
2024
Q2 		$168K Hold
1,179
– – 0.04% 142
2024
Q1 		$151K Buy
1,179
+105
+10% +$12.5K 0.04% 156
2023
Q4 		$111K Buy
1,074
+16
+2% +$1.58K 0.03% 191
2023
Q3 		$96.2K Buy
1,058
+150
+17% +$13.2K 0.03% 178
2023
Q2 		$72.3K Hold
908
– – 0.02% 189
2023
Q1 		$72.3K Hold
908
– – 0.02% 197
2022
Q4 		$61K Hold
908
– – 0.02% 222
2022
Q3 		$45K Hold
908
– – 0.02% 215
2022
Q2 		$51K Hold
908
– – 0.04% 120
2022
Q1 		$50K Sell
908
-202
-18% -$10.4K 0.03% 125
2021
Q4 		$62K Hold
1,110
– – 0.04% 126
2021
Q3 		$53K Buy
+1,110
New +$53.7K 0.03% 133
2017
Q3 		– Sell
-3,000
Closed -$64K – 226
2017
Q2 		$64K Buy
+3,000
New +$60.5K 0.05% 150

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Clearstead Trust's NVO Position: Q2 2026 in Review

Clearstead Trust reduced its Novo Nordisk (NVO) stake by 3.4% in Q2 2026, selling an estimated $10.1K and leaving 6,678 shares worth $320K. The position accounts for 0.04% of the portfolio, ranked #147.

Clearstead Trust first reported a position in NVO in Q2 2017 and has held it in 21 quarters since. The position peaked at $739K in Q2 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Clearstead Trust held 6,678 shares of Novo Nordisk worth $320K as of Q2 2026.
  • Clearstead Trust sold 234 Novo Nordisk shares in Q2 2026, an estimated $10.1K.
  • Novo Nordisk made up 0.04% of Clearstead Trust's portfolio in Q2 2026, its #147 holding.
  • Clearstead Trust first reported a position in Novo Nordisk in Q2 2017 and has held it in 21 quarters since.
  • Clearstead Trust's Novo Nordisk position peaked at $739K in Q2 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.